News

Bill & Melinda Gates Foundation has awarded EPFL-based non-profit iM4TB $2.45 million for PBTZ169 clinical trials


11 May 2017
by Working Group

iM4TB is a non-profit based in EPFL’s Innovation Park. Founded in 2013, its mission is “to develop better and faster-acting medicines to fight TB and therefore bridge the gap between the scientific discovery and the market in order to provide affordable TB treatment to anyone in the world.” 

iM4TB is chaired by Professor Stewart Cole, a world-renowned TB expert, who also directs EPFL’s Global Health Institute. The non-profit enjoys the patronage of Professor Françoise Barré-Sinoussi, a French virologist who won the Nobel Prize in Medicine (2008) for the discovery of HIV, the virus that causes AIDS. 

iM4TB has developed a novel anti-TB drug called PBTZ169 (license held by EPFL). The antibiotic has now proven effective in pre-clinical trials, while previous in vivo studies have shown that it works faster and more effectively than anti-TB drugs currently recommended by the World Health Organization.

PBTZ169 works by preventing the TB bacterium, Mycobacterium tuberculosis, from building its waxy cell envelope, which protects the bacterium from attack by the patient’s immune system and antibiotics. By effectively destroying the envelope, PBTZ169 can kill drug-resistant TB bacteria, and potentially shorten therapy.

For full article click here

More News
26 Jun 2018
As the global TB drug development community pushes forward to find new drug candidates and develop novel regimens to combat the TB epidemic, we'd like to highlight some updates in the field, WGND activities, and upcoming events in 2018. An Interactive Civil Society Hearing was held on June 4th in...
21 May 2018
Bloomberg News reported this week on how world leaders can be successful in ending TB by 2030 and the demographics that TB affects most. One article discusses multi-drug and extensive drug resistant patients as well as challenges, funding needs, and the needs for new tools to defeat TB. The other...
17 Apr 2018
A new laborartory resource handbook was published in March 2018 to support TB clinical trials. The authors and summary of the handbook are below. Please click here for a link to the full handbook. Authors Kathleen Eisenach, University of Arkansas for Medical Sciences, USA Anne-Marie Demers, Desmond...